Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.

This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.

Investigations into cases of wrongdoing by professors are increasingly in the public eye. But are colleges and universities doing enough to deal with the problem?

Former AmpliMed CEO Rob Ashley is as quick on the race track as he is in the fast-paced world of drug development.

The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.

The network effect can improve the ways that biomedical researchers collaborate.

Despite a solid understanding of the biological basis of fragile X syndrome, researchers have struggled to develop effective treatments.

Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system

Scientists are beginning to unravel the mechanisms behind the therapeutic effects of psychedelic drugs.

SPREADING THE WORD: Materials developed by NIDA use a neuroscience approach to teach students about the dangers of drug abuse. A new program from the National Institute on Drug Abuse (NIDA), "Mind Over Matter," is using neuroscience research results to teach, rather than preach to, students about the dangers of addictive drugs. "People have historically seen drug abuse as purely a social problem that results from voluntary behavior and remains voluntary. But science has taught us that addictio